Kutshanje, i-National Medical Products Administration yaseTshayina ivumile ngokusesikweni unyango oludibeneyo lwe-Anlotinib Hydrochloride kunye nePenpulimab yiChia Tai Tianqing kunyango lokuqala lwe-hepatocellular carcinoma. Oku kubonisa uphawu lweshumi oluvunyiweyo lwe-Anlotinib Hydrochloride, olubonisa ukhetho olubalulekileyo olutsha kwicandelo lonyango oluphambili lomhlaza wesibindi. Olu nyango lusekelwe kuphando lweklinikhi lweSigaba sesiThathu olupapashwe kwijenali ye-oncology edumileyo kwihlabathi liphela *The Lancet Oncology*, kunye nedatha yalo yokusebenza okumangalisayo ezisa ithemba elitsha kwizigulana kwihlabathi liphela.
**Impumelelo yoPhando: Ikwandisa kakhulu ukusinda kwaye inciphisa umngcipheko wesifo**
Olu phononongo, olubizwa ngokuba yi-ALTN-AK105-III-02, luvavanyo lweklinikhi lweSigaba III oluneziko ezininzi, olucwangcisiweyo, oluvulelekileyo, olulawulwa ngokulinganayo oluyilelwe ukuvavanya ukusebenza kwe-Anlotinib Hydrochloride edityaniswe nePenpulimab xa kuthelekiswa neyeza eliqhelekileyo lendabuko iSorafenib kunyango lokuqala lwe-hepatocellular carcinoma ephucukileyo. Olu phononongo lubhalise izigulane ezingama-649 ezinomhlaza wesibindi ophucukileyo, apho phantse i-41% yazo yayine-macrovascular invasion, kwaye malunga ne-49.2% yayinamanqanaba aphezulu e-alpha-fetoprotein (≥400 ng/mL). Ezi mpawu zihlala zibonisa imingeni emikhulu yonyango.
Iziphumo zophando ziyakhuthaza:
- **Ukwandiswa Okubalulekileyo Kokusinda Okungenankqubela:** Ixesha eliphakathi lokusinda okungenankqubela kwiqela lonyango oludibeneyo lifikelele kwiinyanga eziyi-6.9, lidlula kakhulu iinyanga eziyi-2.8 kwiqela lolawulo, kunye nokuncipha kwama-47% komngcipheko wokuqhubela phambili kwesifo okanye ukufa.
- **Uphuculo Oluphawulekayo Ekuphileni Ngokupheleleyo:** Ukuphila okuphakathi kweqela lonyango oludibeneyo bekuziinyanga ezili-16.5, xa kuthelekiswa neenyanga ezili-13.2 kwiqela lolawulo, nto leyo ebonisa ukwehla kwe-31% kumngcipheko wokufa.
Olu lwazi "oluneziphumo ezimbini ezilungileyo" alubonisi nje kuphela iingenelo zolu nyango ekulibaziseni ukuqhubela phambili kwesifo kodwa lukwabonisa impumelelo enkulu kwiingenelo zokusinda ngokubanzi, lubonelela ngeendlela zonyango ezisebenzayo ngakumbi kwizigulana ezinomhlaza wesibindi oqhubele phambili.
**ISebe leSibhedlele se-Oncology saseBeijing South Region International: Iqabane lakho leHlabathi lokuLwa noMhlaza**
Xa ujongene nomhlaza, ukufikelela ngexesha elifanelekileyo kulwazi lwezonyango olusemthethweni kunye nenkxaso yonyango lobuchwephesha kubalulekile. ISebe leMicimbi yeHlabathi leSibhedlele i-Oncology saseBeijing South Region lizinikele ekuboneleleni ngeenkonzo ezipheleleyo zokuxilonga i-oncology kunye nonyango lwezigulane zamazwe ngamazwe, kubandakanya neengcebiso malunga nonyango lwamva nje, ucwangciso lonyango lomntu ngamnye, kunye noncedo lonxibelelwano olusebenzisa ulwimi oluhlukeneyo. Sisebenzisana ngokusondeleyo namaziko ophando asekhaya nakwamanye amazwe ukuqinisekisa ukuba izigulane ziyazuza kwiinkqubela phambili eziphambili ezifana nonyango oludibeneyo lwe-Anlotinib Hydrochloride.
**Iinkcukacha zoQhagamshelwano: Silapha ukukunceda**
Ukuba wena okanye abantu obathandayo nifuna iindlela zonyango lomhlaza wesibindi oqhubele phambili okanye ezinye iithumba, nceda unxibelelane nathi ngoko nangoko ngale ndlela ilandelayo. Iqela lethu leengcali liza kubonelela ngeentshayelelo zonyango ezineenkcukacha, isikhokelo senkqubo yezonyango, kunye nenkxaso kwizigulana zamazwe ngamazwe:
- **Ifowuni:** 400-880-3716
Fowunela le nombolo ukuze uthethe ngqo nabaququzeleli bethu bezigulane bamazwe ngamazwe ukuze ufumane iingcebiso ezikhawulezileyo kunye noncedo lokuqeshwa.
- **WeChat:** 17801183037
Yongeza iakhawunti yethu esemthethweni yeWeChat ukuze ufumane ulwazi lonyango olufumaneka ngexesha langempela, imibuzo ekwi-intanethi, okanye iingxoxo ngevidiyo.
- **I-imeyile:**
① 100085_010@163.com
② myimmnet@163.com
Thumela iirekhodi zonyango okanye imibuzo kwi-imeyile yethu, kwaye iqela lethu leengcali liza kubonelela ngeengcebiso zonyango ezenzelwe wena.
**Kutheni Ukhetha Thina?**
- **Ukufikelela kwiiNyango eziPhambili:** Silandela rhoqo iindlela zonyango lwe-oncology kwihlabathi liphela ukuqinisekisa ukuba izigulana zinethuba lokufumana izisombululo ezintsha ezifana nonyango oludibeneyo lwe-Anlotinib Hydrochloride.
- **Iinkonzo zeelwimi ezininzi:** Sinikezela ngenkxaso kwiilwimi ezininzi, kuquka nesiNgesi, ukuze kususwe imiqobo yonxibelelwano kwaye kuqinisekiswe amava angenamthungo kwizigulane zamazwe ngamazwe.
- **Uncedo olupheleleyo:** Ukususela kwizicelo ze-visa kunye namalungiselelo okuhlala ukuya kulandelelwano lonyango, sinikezela ngeenkonzo zononophelo olukhawulezileyo.
Unyango lomhlaza lukhuphiswano oluya kudlula kwixesha. Ukuvunywa konyango oludibeneyo lwe-Anlotinib Hydrochloride kuzise ithemba elitsha kwizigulane ezinomhlaza wesibindi oqhubele phambili. Nokuba ukuphi na, iSebe leSibhedlele i-Beijing South Region Oncology International likulungele ukuba liqabane lakho eliqinileyo kuhambo lwakho lokulwa nomhlaza. Qhagamshelana nathi namhlanje ukuze uqale uhambo lwakho lonyango olulungiselelwe wena!
**Khumbula Ulwazi Lwethu Lonxibelelwano:**
Ifowuni: 400-880-3716
I-WeChat: 17801183037
Email: 100085_010@163.com or myimmnet@163.com
Silangazelela ukukunika inkxaso yezonyango yobungcali neyobubele!
Ixesha leposi: Jan-27-2026